Evaluation of the Frequency, Risk Factors, and Outcomes of ROP in Infants with a BW >1500 Grs or GA ≥33 Wks in Turkey.

Launched by BASKENT UNIVERSITY ANKARA HOSPITAL · Feb 10, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a condition called Retinopathy of Prematurity (ROP), which affects the eyes of premature infants. The researchers are looking at how common ROP is, what factors might lead to its development, and the outcomes for the infants affected. They will be screening preterm babies in Turkey who have a birth weight over 1500 grams or were born at 33 weeks of pregnancy or later. The trial is taking place in 94 neonatal intensive care units (NICUs) from August 2023 to August 2024.

To be eligible for this study, infants must meet the birth weight or gestational age criteria and be identified by their doctors as at risk for ROP. Unfortunately, infants who pass away before their first eye examination cannot participate. Parents or guardians of eligible infants can expect their babies to be monitored for ROP, and the study will help gather important information about how to better identify and treat this condition in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Infants with BW \>1500 g or ≥33 weeks' gestation who were determined to be at risk for ROP by the attending clinician and were screened for ROP.
• Exclusion Criteria:
• • Neonates who died before the first ROP examination are excluded from the study.